Receiving IP is only the beginning. Explore how the first patient visit can expose gaps in dispensing, delegation, IRT, documentation, and site readiness.
- One IP Receipt Problem Is An Exception. Four Is A Process.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Your IP Shipment Arrives At 07:00. Who Opens The Box?
- Segregation Of Duties: Drug Accountability Needs Three Separate Roles
- When Clinical Demand Becomes A Supply Plan
- Before The Excursion: The Governance Decisions That Should Already Be Made
- Clinical Trial Supply Chains Are Moving From Planning For Stability To Preparing For Uncertainty
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
ON-DEMAND WEBINARS
Investigational products present a distinctly high-risk environment for labeling and barcoding. Explore best practices for barcoding solutions that allow for improved medication safety in clinical trials.
Individual data points over time can provide precise drug dosing histories that enable better understanding of protocol adherence, safety, efficacy, PK/PD and a drug’s exposure-response relationship.
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![China Globe World]( "Optimizing Clinical Trials In China With Strategic Solutions For Supply Chain")
Optimizing Clinical Trials In China With Strategic Solutions For Supply ChainPlan proactively for clinical trials in China by aligning with National Medical Products Administration requirements and leveraging Free Trade Zones to streamline regulatory approvals and clinical supply importation.
-
![GettyImages-2169608710-blister-packaging-pill-nutraceutical]( "Rare Diseases And The Integrated CDMO Support System")
Rare Diseases And The Integrated CDMO Support SystemChampion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
![IRT Getty 1407865352]( "3 Study Areas Where Your IRT Vendor Should Do More")
3 Study Areas Where Your IRT Vendor Should Do MoreFind out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
-
![iStock-1214764688-scientist-lab-analyze-research]( "Global Clinical Supply Solutions For Every Trial")
Global Clinical Supply Solutions For Every TrialA reliable clinical supply chain strategy is as essential as a company’s discovery program. Seek a partner who can help guide a comprehensive strategy and manage day-to-day activities.
-
![Supply Chain - Getty- 1159559071]( "European Clinical Supply Planning – Balancing Cost, Flexibility, And Time")
European Clinical Supply Planning – Balancing Cost, Flexibility, And TimeBy evaluating the key parameters of a study, sponsors can identify the most effective location for packaging and distributing clinical trial supplies.
-
![check computer for vitals-GettyImages-1446748436]( "Finding The Optimal IRT/RTSM Design For Your Clinical Trial")
Finding The Optimal IRT/RTSM Design For Your Clinical TrialDetermine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.
-
![GettyImages-1331571740-supply-chain-sourcing-logistics-tracking]( "The Dual Sourcing Approach")
The Dual Sourcing ApproachHaving a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
-
![Getty-1652511983-supply-chain-management]( "Increasing Efficiency And Reducing Drug Waste")
Increasing Efficiency And Reducing Drug WasteDiscover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
-
![GettyImages-1156884561-fill-finish]( "Key Considerations For Selecting Flexible Fillers")
Key Considerations For Selecting Flexible FillersFlexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Outgrowing Excel: Implementing RTSM In A Live Phase I Trial")
Outgrowing Excel: Implementing RTSM In A Live Phase I TrialLearn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
